+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Scandinavia-Europe

  • ID: 4861669
  • Report
  • September 2019
  • Region: Global
  • 89 Pages
  • FinGlobe, Inc
1 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Blueclinical
  • Genmab A/S
  • Lunaphore Technologies SA
  • Orion Corporation
  • Sectra AB
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations that took place between the healthcare companies of Scandinavia and Europe during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as key countries, healthcare sub-sectors, market capitalization groups, medicine groups, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of Scandinavia and Europe.

Analytical data coverage:
  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 110+ healthcare licensing news between Scandinavian (102) and other European (24) companies
  • Small-mid-large cap companies covered-LargeCap (8%), SmallCap (10%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered-Pharmaceuticals (25%), Biotech (28%), Medical Devices (27%), Healthcare Services (20%)
  • 14 medicine groups studied-Oncology (32%), Dermatology (9%), Radiation Oncology (8%)
  • 8+ variables analyzed
Key Features:
  • 8 months’ healthcare licensing transactions between Scandinavia and Europe analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Scandinavian and European healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between Scandinavian and European companies
  • Investors analyzing varied kinds of transaction options for licensing deals between Scandinavia and Europe
Key analysis provided: January-August 2019
  • Total number of licensing deals signed between the companies of Scandinavia and Europe
  • Total number of companies/institutes of Scandinavia and Europe involved in the licensing deals
  • Most licensing deals signed by which European country’s companies with Scandinavian companies
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Blueclinical
  • Genmab A/S
  • Lunaphore Technologies SA
  • Orion Corporation
  • Sectra AB
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions between Scandinavia and Europe licensed during last eight months
1.1 Companies with most licensing deals for Scandinavia and Europe
1.2 Healthcare sub-sectors with most licensing deals
1.3 Market capitalization groups with most licensing deals
1.4 Medicine groups most active in licensing deals
1.5 Licensing payment arrangements most followed
1.6 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals between Scandinavia and Europe by key attributes during last eight months
2.1 For each of the key countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the marketcap groups
2.4 For each of the medicine groups

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed between Scandinavia and Europe during last eight months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By country and company name
Appendix 6 List of not-for-profit groups covered - By country and institute name
Appendix 7 List of companies/institutes covered - By medicine group and company name
Appendix 8 List of companies/institutes covered - By terms of payment and company name
Appendix 9 Licensing deals discontinued between Scandinavia and Europe during last eight months
Note: Product cover images may vary from those shown
3 of 3
  • 2cureX AB
  • 3P Biopharmaceuticals S.L
  • Aarhus University
  • Abzena plc
  • ADDvise Group AB
  • ADEXILIS AG
  • Advanced Global Health
  • Affibody AB
  • AKL Research & Development Ltd
  • Almirall, S.A.
  • Animalcare Group plc
  • Anthrop Pharmaceuticals AB
  • Antony Medical Imaging Center
  • Apoteket AB
  • Aptahem AB
  • Arteriomed GmbH
  • Bactiguard AB
  • Bayer AG
  • Beactica AB
  • Belina Pharma AB
  • BioArctic AB
  • Biohit Oyj
  • BioInvent International AB
  • Bioneer A/S
  • Bioservo Technologies AB
  • BliNK Biomedical SAS
  • Blueclinical
  • Boehringer Ingelheim GmbH
  • Calliditas Therapeutics AB
  • Cantargia AB
  • Carbios SA
  • Cartana AB
  • CCS Healthcare AB
  • Cellink AB
  • Cereno Scientific AB
  • Clinical Laserthermia Systems AB
  • Coalition for Epidemic Preparedness Innovations
  • C-Rad AB
  • CureVac AG
  • Danish Breast Cancer Cooperative Group
  • Deventer Hospital
  • Difar Distribuzione s.r.l
  • Diurnal Group plc
  • Double Bond Pharmaceutical International AB
  • Dr. Falk Pharma GmbH
  • Elekta AB
  • Emeriti Bio AB
  • Erlangen University Hospital
  • ERS Genomics Ltd.
  • E-therapeutics PLC
  • Euromed Swiss AG
  • Euroresearch Srl
  • ExpreS2ion Biotech Holding AB
  • Ferring Holding SA
  • GAIA AG
  • Genmab A/S
  • GENSPEED Biotech GmbH
  • Gubra
  • Heart2Save Oy
  • Helix2
  • Herantis Pharma Plc
  • IBA Dosimetry GmbH
  • Immunovia AB
  • Inhalation Sciences Sweden AB
  • Institute of Energy Technology
  • Integrum AB
  • Intervacc AB
  • Invent Medic Sweden AB
  • Ion Beam Applications S.A
  • Isala Oncologisch Centrum
  • Kappa Bioscience AS
  • Karolinska Institutet
  • Karolinska University Hospital
  • Kromek Group PLC
  • LEO Pharma A/S
  • LGC Group
  • Lidds AB
  • Lipum AB
  • Lokon Pharma AB
  • London Clinic (The)
  • London International Patient Services Limited
  • Lunaphore Technologies SA
  • Mats Nilsson Lab, Stockholm University
  • Medim Sp. z o. o
  • Mentice AB
  • Merck KGaA
  • Moberg Pharma AB
  • Mobidiag Ltd.
  • Molnlycke Health Care AB
  • MVZ Uhlenbrock & Partner GmbH
  • MyCartis NV
  • NeuroVive Pharmaceutical AB
  • Nexstim Oyj
  • NOGGO e. V
  • Nordic Bioscience A/S
  • Nordic Nanovector ASA
  • Novimmune SA
  • Novo Nordisk A/S
  • Novo Nordisk Pharmatech A/S
  • Novozymes A/S
  • Nuevolution AB
  • OncoImmunity AS
  • Oncoinvent AS
  • Oncology Venture A/S
  • OPASCA GmbH
  • OptiBiotix Health PLC
  • Orexo AB
  • Orion Corporation
  • Oroboros Instruments
  • Ortoma AB
  • Oslo University Hospital
  • Oxford University Hospitals NHS Foundation Trust
  • Patheon Biologics B.V.
  • Paxman AB
  • PCI Biotech Holding ASA
  • Peptonic Medical AB
  • Perimed AB
  • Pharmacolog AB
  • Physidia SA
  • Pilloxa AB
  • POA Pharma Scandinavia AB
  • Primex Pharmaceuticals AG
  • QIAGEN N.V.
  • Radboud University Medical Center
  • Radiometer Medical ApS
  • RaySearch Laboratories AB
  • Redsense Medical AB
  • Roche Holding AG
  • RTsafe
  • Sahlgrenska University Hospital
  • Sandoz Nordics
  • Scandion Oncology A/S
  • Sectra AB
  • SensID GmbH
  • Senzime AB
  • Siemens Healthineers AG
  • Skandionkliniken
  • SmartCompounders B.V.
  • Solural Pharma ApS
  • STADA Arzneimittel AG
  • Swedish Orphan Biovitrum AB
  • Swedish University of Agricultural Sciences
  • Swiss Medical Network SA
  • SyntheticMR AB
  • Targovax ASA
  • Tataa Biocenter AB
  • Teva Sweden AB
  • TILT Biotherapeutics Ltd
  • Transgene SA
  • Trimb Healthcare AB
  • Umeå University
  • University College London
  • University Hospital Bispebjerg
  • University of Copenhagen
  • University of Huddersfield
  • Uppsala University
  • Uppsala University Hospital
  • VibroSense Dynamics AB
  • Vingmed Holding A/S
  • Virogates A/S
  • Vision RT Ltd.
  • Vlaams Instituut voor Biotechnologie
  • Xbrane Biopharma AB
  • Xvivo Perfusion AB (publ)
  • Zealand University Hospital
  • Zelluna Immunotherapy AS
Note: Product cover images may vary from those shown
Adroll
adroll